BENITEC BIOPHARMA LIMITED SHARE SUBSCRIPTION AGREEMENTShare Subscription Agreement • June 1st, 2017 • Benitec Biopharma LTD/ADR • Pharmaceutical preparations • New South Wales
THIS SHARE SUBSCRIPTION AGREEMENT (the “Agreement”) is made and entered into as of October 24, 2016 by and among BENITEC BIOPHARMA LIMITED, an Australian corporation (“Company”), and Nant Capital, LLC, a Delaware limited liability company (the “Purchaser”).
EXCLUSIVE SUBLICENSE AGREEMENTExclusive Sublicense Agreement • June 1st, 2017 • Benitec Biopharma LTD/ADR • Pharmaceutical preparations • California
This Exclusive Sublicense Agreement (this “Agreement”) is made and entered into as of the 23rd day of December, 2016 (“Effective Date”), by and between Benitec Biopharma Limited, a company organized under the laws of Australia with its principal business at 99 Mount Street, North Sydney NSW 2060, Australia (“Benitec”), and NantWorks, LLC, a Delaware limited liability company with its principal business at 9920 Jefferson Boulevard, Culver City, California 90232 (“NantWorks”).
RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • June 1st, 2017 • Benitec Biopharma LTD/ADR • Pharmaceutical preparations • New South Wales
This RESEARCH COLLABORATION AGREEMENT (including the exhibits hereto, this “Agreement”) is made as of January 27, 2017 (the “Effective Date”) by and between Benitec Biopharma Limited, an Australian corporation (“Benitec”), and Nant Capital, LLC, a Delaware limited liability company (“Nant”). Nant and Benitec are each referred to herein as a “Party” and, collectively, as the “Parties”. Capitalized terms used and not otherwise defined herein have the meanings set forth in the Subscription Agreement (as defined below).
